Circadian Rhythm Disruption and Your Genetics

By the ExomeDNA Science Team

This page contains general information only. For personal health decisions, consult a qualified clinician.

Circadian rhythm disruption describes a blunting of the natural 24-hour contrast between active and restful periods — measured objectively as low relative amplitude of rest-activity cycles on wrist actigraphy. Below: how researchers measure this trait at population scale, the molecular clock machinery linking your genetics to daily rhythm strength, what a genome-wide study of 71,500 individuals found, and six evidence-based lifestyle levers for reinforcing circadian amplitude.

What is circadian rhythm disruption?

Every cell in the human body keeps rough time through an interlocking set of molecular feedback loops collectively called the circadian clock. The master pacemaker sits in the suprachiasmatic nucleus (SCN) of the hypothalamus, which synchronises peripheral clocks in the liver, heart, immune cells, and nearly every other tissue type. When this system operates well, the contrast between waking activity and nighttime rest is sharp and consistent — a pattern researchers call high relative amplitude.

Circadian rhythm disruption, in the sense studied by large-scale genomic research, refers to a measurable blunting of that contrast. Rather than requiring a clinical sleep complaint, modern population studies use wrist-worn accelerometers worn continuously for seven days or more. The device records minute-by-minute movement. From this stream of data, researchers extract a parameter called relative amplitude: the ratio of activity during the ten most-active hours to activity during the five least-active hours. A high relative amplitude means clear, consistent separation between active days and restful nights. A low relative amplitude — the detrimental direction in this trait — means that separation is blurred: nights are more fragmented, days are less vigorous, or both.

This objective, actigraphy-derived measure captures something distinct from self-reported sleep duration or insomnia. A person can report sleeping eight hours a night and still have a low relative amplitude if their sleep is fragmented or their daytime activity is low. Conversely, someone may report no sleep complaint but their accelerometer data reveals chronically blunted rest-activity contrast. The phenotype therefore reflects the functional output of the entire circadian system — not just one subjective symptom.

Circadian disruption at the population level is associated with increased risk of cardiometabolic conditions, impaired immune regulation, mood disturbance, and cognitive performance decrements. These associations are thought to arise partly because circadian misalignment disrupts the timed release of cortisol, insulin sensitivity fluctuations, immune cytokine rhythms, and neurotransmitter cycling — all of which depend on robust daily oscillation.

The genetics behind circadian rhythm disruption

The molecular clock is built from two interlocking transcription-translation feedback loops. In the primary loop, the proteins CLOCK and BMAL1 form a heterodimer that drives transcription of the Period (PER1, PER2, PER3) and Cryptochrome (CRY1, CRY2) genes. As PER and CRY proteins accumulate, they translocate back into the nucleus and inhibit CLOCK/BMAL1 — suppressing their own transcription. This negative feedback produces an approximately 24-hour oscillation. The timing of this oscillation depends critically on how quickly PER and CRY proteins are degraded or stabilised, which is where ubiquitin-proteasome machinery, kinase activity, and chromatin accessibility all become relevant.

The gene PRKCD encodes protein kinase C delta (PKCδ), a serine/threonine kinase activated by diacylglycerol. PKCδ directly phosphorylates CRY1, CRY2, and BMAL1 — core proteins of the molecular clock — influencing their stability and the rate at which the feedback loop cycles. PKC signalling therefore represents a direct molecular bridge between cellular metabolic and signalling states and the speed and amplitude of the circadian oscillator. Genetic variants that alter PRKCD activity could modulate how tightly the clock feedback loop is maintained, potentially shortening or lengthening period length or reducing oscillation amplitude.

Two genes associated with this trait are predicted E3 ubiquitin ligases: RNF157 (RING finger protein 157) and ANKIB1 (ankyrin repeat and IBR domain-containing 1). Ubiquitin-mediated protein degradation is essential for circadian timekeeping — the timely destruction of PER proteins each cycle resets the clock for the next 24-hour oscillation. Variants in ubiquitin ligase genes expressed in neurons could alter the rate at which clock proteins are cleared, shifting amplitude or period.

DAXX encodes a multifunctional nuclear protein that partners with ATRX to incorporate histone variant H3.3 into chromatin. This chromatin remodelling activity affects the accessibility of gene promoters, including those of circadian clock genes. The rhythmic opening and closing of chromatin at clock gene loci is itself part of the circadian programme; disruption of DAXX-mediated histone incorporation could alter the amplitude of transcriptional oscillations that drive the clock.

Similarly, SFMBT1 (scm-like with four mbt domains 1) is a chromatin-binding protein and member of the Polycomb group complex, an epigenetic regulatory system that controls gene expression programmes in neurons. Polycomb group activity shapes the chromatin state at clock gene loci, and variants affecting SFMBT1 could influence the depth and consistency of circadian gene expression cycles.

SLC25A17 encodes a mitochondrial membrane transporter that moves CoA, FAD, FMN, and NAD across the mitochondrial and peroxisomal membranes. NAD+ levels oscillate with the circadian clock — they are controlled in part by the enzyme NAMPT, whose transcription is driven by CLOCK/BMAL1. NAD+ in turn activates SIRT1, a deacetylase that modifies BMAL1 and PER2, feeding back to regulate clock protein activity. SLC25A17's role in mitochondrial NAD and CoA transport therefore places it at the intersection of cellular energy metabolism and circadian output: variants affecting transport capacity could alter the amplitude of the NAD+ oscillation and, with it, the SIRT1-dependent modulation of the molecular clock.

Finally, NFASC encodes neurofascin, a cell adhesion molecule concentrated at axon initial segments and nodes of Ranvier. Its primary role is maintaining the architecture of neural circuits. While neurofascin is not a direct clock component, it is relevant to the integrity of the brain networks — including SCN connectivity and downstream output pathways — that coordinate circadian signals across brain regions and to peripheral tissues.

Together, these genes implicate several distinct molecular mechanisms: direct kinase modification of clock proteins (PRKCD), ubiquitin-mediated clock protein turnover (RNF157, ANKIB1), chromatin accessibility at clock gene promoters (DAXX, SFMBT1), metabolic coupling via NAD+ cycling (SLC25A17), and neural circuit integrity for circadian output (NFASC).

What the research says

Research base: Moderate. The primary genome-wide association study underpinning this trait (PMID 30120083, Ferguson et al., 2018) analysed actigraphy-derived rest-activity rhythms in 71,500 participants from the UK Biobank, making it one of the largest circadian phenotype studies to date.

Study design: Participants wore wrist accelerometers continuously for seven days. From the resulting movement data, researchers computed relative amplitude — the ratio of mean activity in the ten most-active hours to mean activity in the five least-active hours — as the primary circadian phenotype. This actigraphy-derived measure provides an objective, device-measured index of rest-activity contrast that does not rely on self-report.

Key finding: Genome-wide association analysis identified genetic loci reaching significance thresholds for association with relative amplitude of rest-activity cycles. The signal near PRKCD, a kinase with direct molecular clock substrates, was among the loci identified, supporting a mechanistic interpretation of the genetic association.

Population scope: The 71,500-participant UK Biobank sample provided substantial statistical power for a complex behavioural phenotype. However, the study population was predominantly of European ancestry, meaning the identified variants and their effect sizes may not generalise uniformly across all ancestries.

Interpretation boundary: A moderate confidence tier reflects the fact that findings rest primarily on a single large discovery study. Effect sizes for individual variants are small — consistent with the polygenic architecture of circadian traits — and independent replication in diverse cohorts would strengthen the evidence base further. The genetic associations identify loci influencing circadian amplitude at the population level; they do not predict individual clinical outcomes.

How circadian rhythm disruption affects you

Circadian rhythmicity is not a single biological function but a temporal organising principle for nearly every physiological system. When the rest-activity contrast is blunted — whether by environmental pressures, lifestyle patterns, or genetic factors that reduce the amplitude of the molecular clock — downstream effects can span multiple organ systems.

Cardiometabolic effects: The circadian clock coordinates daily rhythms in blood pressure, heart rate, insulin sensitivity, lipid metabolism, and glucose homeostasis. Blunted circadian amplitude has been associated in observational studies with higher cardiometabolic risk markers, partly because the timed gating of metabolic processes is disrupted when the clock oscillates with reduced amplitude.

Immune regulation: Immune cell activity — including cytokine release, pathogen response, and inflammatory signalling — follows strong circadian patterns. The timing of fever responses, vaccine efficacy, and inflammatory flares all reflect this underlying rhythmicity. Chronically disrupted circadian amplitude may alter the balance and timing of immune outputs.

Mood and mental health: The circadian system and mood-regulating neurotransmitter systems are tightly coupled. Serotonin, dopamine, and cortisol all exhibit robust daily rhythms. Blunted rest-activity amplitude has been associated in epidemiological research with higher rates of depressive symptoms and mood instability — a relationship that is likely bidirectional.

Cognitive performance: Memory consolidation, executive function, and sustained attention all show circadian variation, with performance typically peaking in the mid-morning to early afternoon. Reduced circadian amplitude — meaning less clear distinction between high-alert and low-alert states — may compress the window of peak cognitive function and impair recovery during sleep.

Higher genetic scores on this trait reflect a polygenic predisposition toward lower relative amplitude of rest-activity cycles. This is a population-level statistical tendency, not a deterministic outcome. Environmental influences — particularly light exposure, sleep schedule consistency, and physical activity timing — are among the most powerful modulators of circadian amplitude and are meaningfully modifiable.

Working with your circadian rhythm disruption result

Because circadian amplitude is shaped by both genetic predisposition and environmental input, lifestyle factors can meaningfully shift the outcome even for those with a higher genetic score. The following evidence-based levers are ranked by strength of chronobiological evidence.

1. Consistent sleep-wake schedule (same wake time daily, including weekends). Irregular wake times are among the most disruptive inputs to the SCN pacemaker. A fixed wake time, even after a short night, anchors the circadian system more effectively than varying it by more than 30-60 minutes. This is the single highest-leverage behavioural intervention for circadian amplitude.

2. Morning light exposure (15-30 minutes of bright natural light within one hour of waking). Light is the primary zeitgeber — the environmental time cue — for the SCN. Morning light suppresses residual melatonin, advances the circadian phase, and reinforces the amplitude of the morning cortisol awakening response. On overcast days, outdoor light still substantially exceeds indoor lighting.

3. Time-restricted eating (TRE) aligned with daylight hours. Eating within a 10-12 hour window (for example, 8 am to 6 pm or 8 am to 8 pm) provides a strong metabolic time cue to peripheral clocks in the liver, gut, and adipose tissue. Irregular or late-night eating sends conflicting timing signals to peripheral clocks while the SCN is attempting to maintain a consistent rhythm.

4. Exercise timing (morning or early afternoon; avoid vigorous exercise within two hours of bedtime). Physical activity is a secondary zeitgeber. Morning and early afternoon exercise reinforces circadian phase by elevating body temperature and cortisol at biologically appropriate times. Late-evening vigorous exercise delays the circadian phase and may fragment sleep.

5. Light hygiene in the two hours before bed. Blue-wavelength light from screens and overhead lighting suppresses melatonin secretion, delaying the circadian signal for sleep onset. Dimming lights, switching to warmer-spectrum lighting, and reducing screen brightness in the pre-sleep window reduces this interference.

6. Minimising chronic circadian misalignment (shift work and frequent jet lag). For those with a genetic predisposition toward lower circadian amplitude, repeated circadian misalignment — particularly night shift work or frequent transmeridian travel — may compound the effect. Strategic scheduling of shift rotation (forward rotation, adequate recovery time between shifts) and targeted light/dark protocols for jet lag recovery can partially mitigate this.

Because circadian disruption intersects with sleep medicine, metabolic health, and mood, individuals with persistent difficulties may benefit from consultation with a clinician who specialises in sleep or chronobiology.

Related traits and genes

Circadian rhythm is a foundational biological timing system, and traits across multiple categories reflect its influence. Within sleep and rest, traits such as sleep duration, sleep timing preference (chronotype), and insomnia risk share genetic architecture with circadian amplitude — variants in clock-adjacent genes affect multiple sleep phenotypes simultaneously. Daytime sleepiness and sleep efficiency are closely downstream of circadian amplitude: a blunted rest-activity cycle often manifests as reduced daytime alertness alongside less restorative nighttime sleep.

Beyond sleep, circadian disruption connects to cardiometabolic traits. Metabolic syndrome components — fasting glucose, blood pressure rhythmicity, and lipid metabolism — all show circadian gating. The NAD+/SIRT1 axis implicated via SLC25A17 also connects to longevity-associated metabolic pathways. Mood-related traits including depressive symptom burden and anxiety are associated with circadian gene variants, reflecting the bidirectional coupling of the clock with serotonergic and dopaminergic systems.

Among the genes implicated in this trait, PRKCD participates in immune signalling and apoptosis pathways beyond its circadian role, meaning variants may have pleiotropic effects across categories. DAXX and SFMBT1 are chromatin regulators with broad effects on gene expression programmes, and their circadian relevance is part of a larger role in neuronal transcriptional control.

ExomeDNA genetic results are for wellness and educational purposes only. Consult a clinician for personalized health guidance.

References: Ferguson A et al. Genome-wide association study of circadian rhythmicity in 71,500 UK Biobank participants and its role in cardio-metabolic health. Commun Biol. 2018;1:105. PMID 30120083.